Back to Market Feed

APTIVUS 250 MG CAPSULE

tipranavir
$16.7859per EA

Strength

250 mg/1

NDC

00597000302

Classification

Brand

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Last Updated

1/1/2025

Active Ingredients

TIPRANAVIR

Approval Type

New Drug (NDA)

FDA Application

NDA021814

On Market Since

7/1/2005

Pharmacological Classes

HIV Protease Inhibitors
Protease Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+5.1%

5Y

+13.6%

All

+73.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
KALETRA 200-50 MG TABLET
Brand
00074401412•AbbVie Inc.
$8.3041
per EA
KALETRA 200-50 MG TABLET
Brand
00074679922•AbbVie Inc.
$8.3041
per EA
NORVIR 100 MG TABLET
Brand
00074234030•AbbVie Inc.
$8.3462
per EA
VIRACEPT 625 MG TABLET
Brand
63010002770•AGOURON
$9.7224
per EA
REYATAZ 200 MG CAPSULE
Brand
00003363112•E.R. Squibb & Sons, L.L.C.
$23.6653
per EA
PREZISTA 600 MG TABLET
Brand
59676056201•Janssen Products LP
$34.9801
per EA
REYATAZ 300 MG CAPSULE
Brand
00003362212•E.R. Squibb & Sons, L.L.C.
$46.9853
per EA
EVOTAZ 300 MG-150 MG TABLET
Brand
00003364111•E.R. Squibb & Sons, L.L.C.
$51.9504
per EA
PREZISTA 800 MG TABLET
Brand
59676056630•Janssen Products LP
$70.1903
per EA